Ambrogio Curtolo

710 total citations
14 papers, 240 citations indexed

About

Ambrogio Curtolo is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Ambrogio Curtolo has authored 14 papers receiving a total of 240 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Infectious Diseases and 5 papers in Molecular Medicine. Recurrent topics in Ambrogio Curtolo's work include Antibiotic Resistance in Bacteria (5 papers), COVID-19 Clinical Research Studies (4 papers) and Bacterial Identification and Susceptibility Testing (3 papers). Ambrogio Curtolo is often cited by papers focused on Antibiotic Resistance in Bacteria (5 papers), COVID-19 Clinical Research Studies (4 papers) and Bacterial Identification and Susceptibility Testing (3 papers). Ambrogio Curtolo collaborates with scholars based in Italy and Myanmar. Ambrogio Curtolo's co-authors include Alessandra Oliva, Mario Venditti, Francesco Cogliati Dezza, Giammarco Raponi, Claudio Maria Mastroianni, Lorenzo Volpicelli, Giancarlo Ceccarelli, Parni Nijhawan, Camilla Ajassa and L. Mantovani and has published in prestigious journals such as Frontiers in Immunology, International Journal of Antimicrobial Agents and Journal of Clinical Medicine.

In The Last Decade

Ambrogio Curtolo

13 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ambrogio Curtolo Italy 8 76 76 61 55 49 14 240
Jeffrey Adelglass United States 9 26 0.3× 110 1.4× 37 0.6× 50 0.9× 41 0.8× 21 265
И. В. Шлык Russia 6 19 0.3× 38 0.5× 71 1.2× 9 0.2× 18 0.4× 46 158
Anna Radice Italy 7 51 0.7× 45 0.6× 47 0.8× 19 0.3× 14 0.3× 11 204
Andrea Zimmer United States 7 24 0.3× 81 1.1× 68 1.1× 13 0.2× 9 0.2× 15 265
Khalid M Dousa United States 12 41 0.5× 189 2.5× 195 3.2× 3 0.1× 38 0.8× 33 311
Laura Cursi Italy 8 49 0.6× 50 0.7× 52 0.9× 2 0.0× 22 0.4× 21 181
Rajalakshmi Arjun India 7 36 0.5× 43 0.6× 43 0.7× 4 0.1× 33 0.7× 29 155
Francesca Ippolita Calò Carducci Italy 8 18 0.2× 58 0.8× 58 1.0× 4 0.1× 26 0.5× 21 163
Adam Parker United States 6 24 0.3× 16 0.2× 56 0.9× 5 0.1× 12 0.2× 10 136
Melike Emiroğlu Türkiye 7 17 0.2× 32 0.4× 62 1.0× 5 0.1× 79 1.6× 38 156

Countries citing papers authored by Ambrogio Curtolo

Since Specialization
Citations

This map shows the geographic impact of Ambrogio Curtolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ambrogio Curtolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ambrogio Curtolo more than expected).

Fields of papers citing papers by Ambrogio Curtolo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ambrogio Curtolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ambrogio Curtolo. The network helps show where Ambrogio Curtolo may publish in the future.

Co-authorship network of co-authors of Ambrogio Curtolo

This figure shows the co-authorship network connecting the top 25 collaborators of Ambrogio Curtolo. A scholar is included among the top collaborators of Ambrogio Curtolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ambrogio Curtolo. Ambrogio Curtolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Oliva, Alessandra, S. Covino, Ambrogio Curtolo, et al.. (2024). Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study. European Journal of Clinical Microbiology & Infectious Diseases. 43(6). 1149–1160. 12 indexed citations
2.
Oliva, Alessandra, Ambrogio Curtolo, Federica Sacco, et al.. (2024). Efficacy of fosfomycin-containing regimens in treating severe infections caused by KPC-producing klebsiella pneumoniae and carbapenem-resistant acinetobacter baumannii in critically ill patients. International Journal of Antimicrobial Agents. 64(6). 107365–107365. 3 indexed citations
3.
Oliva, Alessandra, Francesco Cogliati Dezza, Francesca Cancelli, et al.. (2023). New Antimicrobials and New Therapy Strategies for Endocarditis: Weapons That Should Be Defended. Journal of Clinical Medicine. 12(24). 7693–7693. 2 indexed citations
4.
Oliva, Alessandra, Francesca Cancelli, Ambrogio Curtolo, et al.. (2022). Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literature. IRIS Research product catalog (Sapienza University of Rome). 7 indexed citations
5.
Arcari, Gabriele, Alessandra Oliva, Federica Sacco, et al.. (2022). Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high dosage meropenem: a case report. European Journal of Clinical Microbiology & Infectious Diseases. 41(3). 495–500. 13 indexed citations
6.
Dezza, Francesco Cogliati, Gabriele Arcari, Federica Alessi, et al.. (2022). Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics Compared. Antibiotics. 11(7). 926–926. 24 indexed citations
7.
Oliva, Alessandra, Lorenzo Volpicelli, Ambrogio Curtolo, et al.. (2022). Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae: results from a multicentre retrospective study. JAC-Antimicrobial Resistance. 4(6). dlac121–dlac121. 24 indexed citations
8.
Benvenuto, Domenico, Ambrogio Curtolo, Claudia Palazzolo, et al.. (2022). Aero-Medical Evacuation during SARS-CoV-2 Pandemic: Extraordinary Measure or Emerging Treatment Option?. Journal of Clinical Medicine. 12(1). 133–133.
9.
Zingaropoli, Maria Antonella, Parni Nijhawan, Anna Carraro, et al.. (2021). Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia. Frontiers in Immunology. 12. 627548–627548. 62 indexed citations
10.
Oliva, Alessandra, Cristian Borrazzo, Maria Teresa Mascellino, et al.. (2021). CURB-65 plus hypoalbuminemia: a new score system for prediction of the in-hospital mortality risk in patients with SARS-CoV-2 pneumonia. Infezioni in Medicina. 29(3). 408–415. 5 indexed citations
11.
Oliva, Alessandra, Ambrogio Curtolo, Lorenzo Volpicelli, et al.. (2021). Synergistic Meropenem/Vaborbactam Plus Fosfomycin Treatment of KPC Producing K. pneumoniae Septic Thrombosis Unresponsive to Ceftazidime/Avibactam: From the Bench to the Bedside. Antibiotics. 10(7). 781–781. 18 indexed citations
12.
Dezza, Francesco Cogliati, Ambrogio Curtolo, Lorenzo Volpicelli, et al.. (2020). Are Follow-Up Blood Cultures Useful in the Antimicrobial Management of Gram Negative Bacteremia? A Reappraisal of Their Role Based on Current Knowledge. Antibiotics. 9(12). 895–895. 13 indexed citations
13.
Curtolo, Ambrogio, Alessandra Oliva, Lorenzo Volpicelli, et al.. (2020). Monocyte absolute count as a preliminary tool to distinguish between SARS-CoV-2 and influenza A/B infections in patients requiring hospitalization.. PubMed. 28(4). 534–538. 3 indexed citations
14.
Bettoli, Vincenzo, Marco Manfredini, M. Libanore, et al.. (2018). Rates of antibiotic resistance/sensitivity in bacterial cultures of hidradenitis suppurativa patients. Journal of the European Academy of Dermatology and Venereology. 33(5). 930–936. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey Adelglass Breakdown of academic impact, for papers by И. В. Шлык Breakdown of academic impact, for papers by Anna Radice Breakdown of academic impact, for papers by Andrea Zimmer Breakdown of academic impact, for papers by Khalid M Dousa Breakdown of academic impact, for papers by Laura Cursi Breakdown of academic impact, for papers by Rajalakshmi Arjun Breakdown of academic impact, for papers by Francesca Ippolita Calò Carducci Breakdown of academic impact, for papers by Adam Parker Breakdown of academic impact, for papers by Melike Emiroğlu
Rankless by CCL
2026